Newark, California-based InCarda Therapeutics Inc, a developer of inhaled therapies for cardiovascular diseases, has raised $30 million in financing. The investors included an affiliate of Innoviva Inc, Deerfield Management, HealthCap and Morningside Venture.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: